U.S. Ophthalmic Handheld Surgical Instruments Market Size, Share | Report 2023-2032
The U.S. ophthalmic handheld surgical instruments market was valued at USD 735.31 million in 2022 and it is predicted to surpass around USD 1,069.75 million by 2032 with a CAGR of 3.82% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 735.31 million |
| Revenue Forecast by 2032 | USD 1,069.75 million |
| Revenue Forecast by 2032 | CAGR of 3.82% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Companies Covered | BVI; Accutome, Inc.; Medline Industries, Inc.; Haag-Streit Group; Appasamy Associates; Millennium Surgical Corp; Katalyst Surgical; ASICO, LLC.; INKA Surgical Instruments; Surgical Holdings |
The increasing prevalence of eye disease, favorable government policies, and improving eye care infrastructure to control the burden of eye diseases are the major factors boosting the growth of the ophthalmic handheld surgical instruments market in the U.S.
The COVID-19 pandemic has greatly obstructed every aspect of healthcare delivery in the U.S. The first two months of the pandemic led to a dramatic decline in elective and preventative care, which impacted modalities ranging from procedures and imaging to laboratory tests and vaccinations. Similarly, the field of ophthalmology was not immune to the impact of the pandemic. Elective cataract surgery postponed during the pandemic consistently led to longer wait and possible anxiety among patients. Admission rates of patients in hospitals also declined due to the fear of infection, further reducing the number of eye surgeries performed during the pandemic.
However, with the economies going back to normalcy and the increasing usage of digital services, and a rise in overall screentime post-pandemic, is expected to lead to an increase in ophthalmic diseases. This, in turn, is anticipated to help the market grow at the pre-covid growth rate over the forecast period.
Conditions such as cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy are major causes of visual impairment & blindness globally. An increase in the elderly population is creating a proportionate increase in the number of people suffering from visual impairment and blindness. Thus, leading to a rise in demand for ophthalmic handheld surgical instruments.
For instance, in the U.S., nearly 1.3 million people aged 40 years and older are legally blind (defined as best-corrected visual acuity, worse than or equal to 20/200 in the better-seeing eye). More than 2.9 million people aged 40 years and older have low vision (defined as best-corrected visual acuity worse than 20/40; this number excludes those who are legally blind).
The abovementioned statistics represent the overall eye disease burden in the U.S., contributing to the growing demand for ophthalmic handheld surgical instruments. Moreover, ophthalmic disorders, such as childhood blindness, age-related macular degeneration, trachoma, corneal opacities, and onchocerciasis, are expected to witness the highest occurrence over the forecast period.
U.S. Ophthalmic Handheld Surgical Instruments Market Segmentations:
| By Product | By End-use |
|
Forceps Scissors Chopper Ophthalmic Knives Cannula Others |
Hospitals Ophthalmic Clinics Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Ophthalmic Handheld Surgical Instruments Market
5.1. COVID-19 Landscape: U.S. Ophthalmic Handheld Surgical Instruments Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Ophthalmic Handheld Surgical Instruments Market, By Product
8.1. U.S. Ophthalmic Handheld Surgical Instruments Market, by Product, 2023-2032
8.1.1. Forceps
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Scissors
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Chopper
8.1.3.1. Market Revenue and Forecast (2019-2032)
8.1.4. Ophthalmic Knives
8.1.4.1. Market Revenue and Forecast (2019-2032)
8.1.5. Cannula
8.1.5.1. Market Revenue and Forecast (2019-2032)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2019-2032)
Chapter 9. U.S. Ophthalmic Handheld Surgical Instruments Market, By End-use
9.1. U.S. Ophthalmic Handheld Surgical Instruments Market, by End-use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Ophthalmic Clinics
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 10. U.S. Ophthalmic Handheld Surgical Instruments Market, Regional Estimates and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Forecast, by Product (2019-2032)
10.1.2. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 11. Company Profiles
11.1. BVI
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Accutome, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Medline Industries, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Haag-Streit Group
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Appasamy Associates
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Millennium Surgical Corp
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Katalyst Surgical
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. ASICO, LLC.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. INKA Surgical Instruments
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Surgical Holdings
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers